Effectiveness of Nirmatrelvir–Ritonavir Against the Development of Post–COVID-19 Conditions Among U.S. Veterans: A Target Trial Emulation: Annals of Internal Medicine: Vol 0, No 0 – Annals of Internal Medicine

by

  1. Effectiveness of Nirmatrelvir–Ritonavir Against the Development of Post–COVID-19 Conditions Among U.S. Veterans: A Target Trial Emulation: Annals of Internal Medicine: Vol 0, No 0 Annals of Internal Medicine
  2. Study: Regardless of variant, half of long-COVID patients fail to improve after 18 months University of Minnesota Twin Cities
  3. New COVID-19 data warns of risks to seniors not yet infected CBC News: The National
  4. Paxlovid doesn’t cut risk of long COVID, study finds UPI News
  5. COVID-19 surge: Here’s what Canadian seniors need to know as cases rise CTV News
  6. View Full Coverage on Google News

Read original article here

Leave a Comment